MUC16 and clear cell adenocarcinoma: BMI, body mass index; HR, hazard ratio; NACT; neoadjuvant chemotherapy; NLR, neutrophil-to-lymphocyte ratio; PDS; primary debulking surgery; FIGO: International Federation of Gynecology and Obstetrics; CA-125: cancer antigen-125; LG includes endometrioid carcinoma, clear cell carcinoma, mucinous carcinoma, and low-grade serous carcinomas; HG includes high-grade serous carcinomas.